| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $29.4M | -6.3% | +2.7% |
| Cost of Revenue | $17.8M | -8.8% | -5.3% |
| Gross Profit | $11.6M | -2.3% | +18.0% |
| R&D Expense | $5.4M | +1.6% | -33.9% |
| SG&A Expense | $8.5M | -7.5% | -16.1% |
| Operating Income | -$15.8M | +6.2% | +33.7% |
| Interest Expense | $3.5M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $36.4M | -7.9% | +9.5% |
| Short-term Investments | $142.2M | -1.6% | -0.1% |
| Accounts Receivable | $33.0M | -5.5% | -3.8% |
| Inventory | $49.3M | -5.7% | -19.8% |
| Current Assets | $265.4M | -3.7% | -3.6% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$36.8M | — | — |
| Capital Expenditures | $575K | — | — |
| Investing Cash Flow | -$106.3M | — | — |
| Financing Cash Flow | $55.5M | — | — |
| Free Cash Flow | -$37.4M | — | — |
| +0.0% |
| -42.7% |
| Pre-tax Income | -$17.4M | +5.4% | +37.2% |
| Income Tax | $404K | +288.5% | +122.0% |
| Net Income | -$17.8M | +3.8% | +36.2% |
| EPS (Basic) | -$1.00 | +3.8% | -81.8% |
| EPS (Diluted) | -$1.00 | +3.8% | -81.8% |
| $277.3M |
| -4.0% |
| -5.3% |
| Current Liabilities | $37.4M | +1.5% | -11.7% |
| Long-term Debt | $95.5M | +0.7% | -51.6% |
| Total Liabilities | $134.9M | +0.7% | -45.0% |
| Stockholders' Equity | $142.4M | -8.0% | +197.7% |